Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

ClinicalTrials.gov ID: NCT03733444

Public ClinicalTrials.gov record NCT03733444. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 11:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Doses of GLPG1690 in Addition to Local Standard of Care for Minimum 52 Weeks in Subjects With Idiopathic Pulmonary Fibrosis

Study identification

NCT ID
NCT03733444
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lakefront Biotherapeutics NV
Industry
Enrollment
781 participants

Conditions and interventions

Interventions

  • GLPG1690 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 4, 2018
Primary completion
Mar 29, 2021
Completion
Mar 29, 2021
Last update posted
Jul 28, 2022

2018 – 2021

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Arizona Pulmonary Specialists Phoenix Arizona 85012
University of Arizona College of Medicine Tucson Arizona 85724
Keck School of Medicine of USC Los Angeles California 90033
Cedars Sinai Medical Center Los Angeles California 90048
UC Davis Medical Center Sacramento California 95816
University of California, San Francisco Medical Center San Francisco California 94143
St. Francis Medical Institute Clearwater Florida 33765
University of Miami Miami Florida 33136
Renstar Medical Research Ocala Florida 34470
Central Florida Pulmonary Group PA Orlando Florida 32803
Piedmont Healthcare Atlanta Georgia 30309
Emory University Atlanta Georgia 30322
University of Chicago Medical Center Chicago Illinois 60637
Loyola University Medical Center Maywood Illinois 60153
University of Kansas Medical Center Kansas City Kansas 66160
Brigham and Womens Hospital Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of Michigan Health System (UMHS) Ann Arbor Michigan 48109
Spectrum Health Medical Group Grand Rapids Michigan 49546
University of Minnesota Medical Center Minneapolis Minnesota 55455
Cardio Pulmonary Associates Chesterfield Missouri 63017
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03765
Atlantic Respiratory Institute Summit New Jersey 07901
Lovelace Scientific Resources Inc Albuquerque New Mexico 87108
Albany Medical Center Albany New York 12208
Columbia University Medical Center New York New York 10032
Duke University Medical Center Durham North Carolina 27710
Ohio State University Columbus Ohio 43203
Mercy Health - St. Vincent Medical Center Toledo Ohio 43608
Thomas Jefferson University Philadelphia Pennsylvania 19107
Temple Lung Center Philadelphia Pennsylvania 19140
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Medical University of South Carolina - PPDS Charleston South Carolina 29425
University of Vermont Burlington Vermont 05401
Inova Fairfax Hospital Falls Church Virginia 22042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 96 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03733444, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2022 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03733444 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →